Compare VNDA & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNDA | TG |
|---|---|---|
| Founded | 2002 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.0M | 239.6M |
| IPO Year | 2005 | 1994 |
| Metric | VNDA | TG |
|---|---|---|
| Price | $3.99 | $5.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 273.7K |
| Earning Date | 10-28-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 151.06 |
| EPS | N/A | ★ 0.26 |
| Revenue | $216,105,000.00 | ★ $800,821,000.00 |
| Revenue This Year | $12.05 | N/A |
| Revenue Next Year | $30.61 | N/A |
| P/E Ratio | ★ N/A | $21.79 |
| Revenue Growth | ★ 8.72 | 8.29 |
| 52 Week Low | $3.57 | $5.26 |
| 52 Week High | $9.91 | $10.53 |
| Indicator | VNDA | TG |
|---|---|---|
| Relative Strength Index (RSI) | 43.50 | 30.49 |
| Support Level | $3.57 | N/A |
| Resistance Level | $5.49 | $8.15 |
| Average True Range (ATR) | 0.28 | 0.42 |
| MACD | 0.05 | -0.19 |
| Stochastic Oscillator | 34.42 | 17.78 |
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.